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Summary. The purpose of this study was to ex- 
amine contractile properties of endothelin-1, a 
newly discovered vasoactive peptide, in guinea pig 
coronary resistance vessels and abdominal aorta. 
Changes in perfusion pressure after injections of 
endothelin-1 were measured using a constant-flow 
modified Langendorff preparation. The EDlo 
values of coronary perfusion pressure were about 
100-fold less for endothelin-1 than for prostaglan- 
din F2~. After the endothelium was damaged by 
exposure to free radicals, maximal coronary con- 
striction in response to endothelin-1 (10 -9 moles) 
was not altered, whereas dilator responses to low 
doses of endothelin-1 were converted to constric- 
tor responses. Removal of the endothelium from 
aortic rings significantly increased responsiveness 
to endothelin-1 and the maximal response to the 
peptide. In calcium-free medium, endothelin-1 
induced small increases both in perfusion pres- 
sure in coronary vessels and in tension in the 
aorta. Reintroduction of calcium in the coronary 
and aortic preparations produced a rapid increase 
in perfusion pressure and tension, respectively. 
Further, endothelin-l-induced coronary constric- 
tion was inhibited 59% + 7% by nifedipine (10 -7 
moles). We conclude that endothelin-1 is a more 
potent constrictor than prostaglandin F2, in the 
coronary vasculature. Endothelin-l-induced con- 
striction in the coronary vasculature of the 
guinea pig is not mediated through an endo- 
genous constricting factor released from the endo- 
thelium or a constrictor prostaglandin. Further, 
endothelin-l-induced dilation in the coronary vas- 
culature and attenuation of endothelin-l-induced 
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contraction in the abdominal aorta of the guinea 
pig are mediated through the release of a factor 
from the endothelium. Endothelin-l-induced 
coronary constriction and abdominal aortic con- 
traction require extracellular calcium, entering, in 
part, through nifedipine-sensitive channels. 
Key words: Calcium - Nifedipine - Vascular en- 
dothelium 
Endothelin-1, a newly discovered endothelium- 
derived vasoactive factor [1], has potent in vitro 
contractile properties in dog [2] and pig [3] coro- 
nary vessels and in rat [4] and rabbit [5, 6] aorta, as 
well as potent in vivo pressor effects in the guinea 
pig [7]. The mechanisms through which contrac- 
tion is induced involve the mobilization of ex- 
tracellular calcium [8], release of intracellular 
calcium [5], and activation of nifedipine-sensitive 
calcium channels and nonspecific calcium chan- 
nels [9]. Yanagasawa et al. [1] first hypothesized 
that endothelin-1 was an endogenous calcium 
channel agonist, based on the absence of contrac- 
tion of porcine coronary artery in calcium-free 
medium and inhibition of contraction by nifedi- 
pine. Since that time, investigators have found 
that an increase in perfusion pressure or tension 
was [8, 10, 11] or was not [9, 12] observed in 
calcium-free medium. Further, reports indicate 
that calcium channel blockers inhibit [6, 12], but 
do not abolish, endothelin-l-induced constriction 
or that they have little inhibitory effect [4]. In 
a recent review, Masaki [13] reported that endo- 
thelin-1 working as a calcium channel agonist is 
a hypothesis which has not been substantiated by 
the current literature. 
The present study was undertaken to evaluate 
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t h e  con t r ac t i l e  p r o p e r t i e s  o f  endo the l i n -1  in 
g u i n e a  pig  c o r o n a r y  r e s i s t ance  vesse ls  a n d  ab-  
d o m i n a l  ao r t a .  W h e t h e r  e n d o t h e l i n - l - i n d u c e d  
cons t r i c t i on  a n d  c o n t r a c t i o n  are  e n d o t h e l i u m -  or  
c a l c i u m - d e p e n d e n t  also was  e x a m i n e d .  
Materials and methods 
Male guinea pigs (n = 15) weighing approximately 350 g 
were used in this study. Animals had free access to food and 
water and were group-housed in light-cycled (0600-1800) 
temperature-controlled quarters. 
Two types of physiologic measurements were investigated: 
(1) perfusion pressure in the coronary vasculature using a 
modified Langendorff procedure, and (2) force generation in 
isolated abdominal aortic rings. For coronary vascular perfu- 
sion experiments, guinea pigs were given 300 units of in- 
traperitoneal heparin and killed by a single blow to the head 
while under anesthesia (ketamine, 40 mg/kg and xylazine, 6 
mg/kg). The chest was opened and the heart arrested in situ 
by a 4 ml injection of iced 16 mM KCI into the inferior vena 
cava. The heart was then rapidly excised and the ascending 
aorta cannulated with polyethylene tubing. The coronary vas- 
culature was perfused at a constant flow rate with a buffer 
containing the following (mmol/1): NaCI 105.6, KCI 14.8, 
MgSO4"7H20 1.1, KHzPO 4 1.2, NaHCO3 25.0, dextrose 
11.0, and CaC12-2H20 1.25. The perfusion medium was 
maintained at 37°C and aerated with a mixture of 95% O2 and 
5% CO2. The heart was allowed to equilibrate for at least 20 
min prior to the initiation of the experiment. The flow rate 
was adjusted to a level necessary to generate an initial perfu- 
sion pressure of 25 mmHg. The average coronary flow rate 
was 4 + 1 ml/min. Agents were injected i cm above the heart 
in 0.1 ml amounts using a 1 second bolus technique at 4 min 
intervals. Changes in perfusion pressure were measured using 
a transducer via a t-tube between the flow pump and the 
heart, and recorded on a Grass polygraph. 
Following the equilibration period, the coronary vascula- 
ture was made to constrict to a bolus injection of prostaglan- 
din F2a (PGFza, 10 -7 moles). Subsequent to this treatment, 
coronary vascular tone stabilized at a level that was approx- 
imately 20 mmHg above the initial perfusion pressure. Re- 
sponsiveness to endothelin-1 (10-14-10 -9 moles) was char- 
acterized on this background of coronary vascular tone. In 
another set of experiments, disruption of the endothelium 
was achieved by exposing the vessels to free radicals gener- 
ated by electrolysis of the buffer solution [14]. The perfusate 
was stimulated by platinum wire electrodes within the tubing 
cannulating the ascending aorta 2 em above the suspended 
heart. A 9V stimulus was delivered as a train of square waves 
of 2 ms pulse duration at a frequency of 4 Hz for 5 min. 
Changes in perfusion pressure were measured before and 
after endothelium damage. The absence of dilation to acetyl- 
choline was used to demonstrate endothelium damage. After 
endothelium damage, dose-response curves to endothelin-1 
(10-1'l-10 -9 moles) were obtained. In another set of experi- 
ments, responsiveness to endothelin-1 (t0 -9 moles) was mea- 
sured after perfusion of the coronary vasculature for 20 min 
with calcium-free medium with 1 mM EGTA, after reintro- 
duction of calcium, and after injection of nifedipine (10 -7 
moles). The effect of pretreatment for 30 min with in- 
domethacin (14/xM) on endothelin-l-induced coronary con- 
striction also was determined. 
For isolated vascular ring studies, segments of the abdo- 
minal aorta were excised and placed in a physiological salt 
solution (PSS) of the following composition (mM): NaCI 130, 
KC1 4.7, NaHCO3 14.9, KHzPO4 1.17, CaCI2 1.6, MgSO4 
7H20 1.17, dextrose 5.5, and CaNa: EDTA 0.03. The vessel 
segments were cleaned of excess connective tissue and cut 
into 3-mm ring segments. Two wires were passed through the 
lumen taking care not to damage the endothelium. The en- 
dothelium was removed from some preparations by gently 
rubbing the endothelial surface. The failure of acetylchotine 
(1 /~M) to relax a contraction induced by PGFz~ (0.1 /xM) 
demonstrated the effectiveness of endothelium removal. Af- 
ter the rings were mounted in the bath, a passive tension of 2 
g was applied to each ring and isometric tension was mea- 
sured with a force transducer. The PSS in the tissue bath was 
aerated with 95% Oz and 5% CO2 and maintained at a 
temperature of 37°C. The aortic rings were allowed to equili- 
brate for 60 min before the experiment. 
Initial studies involved quantitating responses of intact and 
denuded aortic rings to increasing bath concentrations of 
endothelin-1 (10-n-3 x 10 -s M). Responses to each concen- 
tration were observed for 10 min before the bath concentra- 
tion of endothelin-1 was increased 3-fold. In a second series 
of experiments, we observed the response to endothelin-t in 
the absence of extracellular calcium. Aortic rings were ex- 
posed to a calcium-free PSS containing 1 mM EGTA for 2 
rain prior to exposure to 10 -s M endothelin-1. After a 10-min 
exposure period, calcium was reintroduced to provide an 
effective concentration of 1.6 mM. The response to 
endothelin-1 was observed for an additional 20 min. 
Synthetic human/porcine endothelin-1 (Peptides Interna- 
tional, Louisville, KY, USA) was mixed with distilled water 
to obtain concentrations of 10 -5 M. Serial dilutions were per- 
formed using either PSS or distilled water. Acetylcholine 
(Miochol, IOLAB Pharmaceuticals, Claremont, CA, USA) 
and prostaglandin F~ (Sigma, St. Louis, MO, USA) were 
diluted in PSS and prepared daily. Nifedipine (Sigma) was 
dissolved in ethanol, and indomethacin was dissolved in 
100mM NaCO3. Data are reported as means + standard error 
of the means (SEM). An unpaired analysis (Student's t-test) 
was used to compare observations between the control and 
treated groups. The Bonferroni correction was used when 
multiple comparisons were made. A P value of 0.05 was con- 
sidered statistically significant. EDs0 values (dose of 
endothelin-1 that caused a half-maximal response in aorta) 
and EDI0 values (dose of endothelin-1 that caused a 10 
mmHg change in peffusion pressure in the coronary vascula- 
ture) were estimated from graphic representations of the 
data. 
Results 
C o r o n a r y  v a s o d i l a t i o n  was  o b s e r v e d  in r e s p o n s e  
to  low doses  o f  endo the l in -1  (10 -14 -10  -12 m o l e s )  
in t he  in tac t  p r e p a r a t i o n  (Fig.  1). A b iphas i c  re-  
s p o n s e ,  init ial  d i l a t ion  fo l lowed  by  cons t r i c t i on ,  
was  o b s e r v e d  a t  a close o f  10 - ix  m o l e s  in 2 o u t  o f  5 
an ima l s .  H i g h e r  d o s e s  o f  e n d o t h e l i n - I  (10 -1° a n d  
10 -9  m o l e s )  i n d u c e d  on ly  inc reases  in p e r f u s i o n  
p r e s s u r e  in all an ima l s  in a d o s e - d e p e n d e n t  
f a sh ion .  C o n s t r i c t o r  r e s p o n s e s  in the  c o r o n a r y  
v a s c u l a t u r e  w e r e  o f  s low o n s e t  a n d  long  las t ing.  
T h e  m a x i m a l  cons t r i c t i on  in r e s p o n s e  to  
e n d o t h e l i n - 1  (10 -9  m o l e s )  o c c u r r e d  b e t w e e n  5 a n d  
30 rain a f t e r  in jec t ion .  F o l l o w i n g  the  final d o s e  o f  
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Fig. 1. Dose-response 
log (moles) 
curves to prostaglandin F2~ and 
endothelin-1 in the coronary resistance vessels ( n = 5 ) .  
Values are means +_ standard error of mean 
endothelin-1, the coronary vasculature was per- 
fused with normal PSS. The increased tone in the 
vessels was only reduced 67% and did not return 
to baseline levels even after continuous perfusion 
for 1 h with fresh PSS. Endothelin-1 has a more 
potent effect in inducing coronary constriction 
than did prostaglandin F2~ (Fig. 1), in that the 
threshold dose which resulted in a 10 mmHg 
increase in perfusion pressure was almost 100- 
fold lower for endothelin-1 than for PGF2, 
[endothelin-1, - l o g  EDlo value = 10.58+0.18 
(antilog = 2.6 × 10 -11 moles); prostagtandin Fz~, 
- l o g  ED10 value = 8.73 + 0.25 (antilog 1.8 × 10 -9 
moles); P < 0.05]. 
Dilator responses to injections of acetylcholine 
10 -7 moles), before electrical stimulation of the 
buffer, were converted to constrictor responses 
after stimulation (perfusion pressure response be- 
fore, - 15  + 3 mmHg; and after, 10 + 3 mmHg; 
P < 0 . 0 5 ) ,  indicating that the endothelium had 
been damaged. After damaging the endothelium, 
dilator responses to low doses of endothelin-1 
were converted to constrictor responses [15] 
and the ED10 values were significantly lower 
[damaged, - l o g  ED10 value = 11.67 + 0.2 
(antilog = 2.1 × 10 -12 moles); intact, - l o g  EDlo 
value = 10.58 + 0.18 (antilog = 2.6 × 10 -11 moles); 
P<0 .05 ]  but the magnitude of endothelin-1- 
induced constriction at 10 -1° and 10 -9 moles was 
not changed (Fig. 2). Pretreatment of the coron- 
ary vasculature for 30 rain with indomethacin (14 
/xM) did not significantly alter constrictor re- 
sponses to endothelin-1 (indomethacin treatment, 
57 + 3 mmHg; intact untreated, 42 + 11 mmHg). 
The protocol used to examine the calcium de- 
pendency of the endothelin-l-induced constriction 
in the coronary circulation is shown in a repre- 
sentative tracing (Fig. 3). Endothelin-1 (10 -9 
moles) produced a large increase in perfusion 
pressure in the presence of 1.25 mM calcium in the 
perfusate. After coronary perfusion with calcium- 
free medium with 1 mM EGTA for 20 min, the 
endothelin-l-induced constriction was significant- 
ly reduced. Subsequent reintroduction of calcium 
(1.25 raM) into the perfusate led to immediate 
increases in perfusion pressure. Cumulative 
observations of coronary endothelin-l-induced 
constriction in calcium PSS (1.25 raM), in calcium- 
free PSS with 1 mM EGTA,  after readdition of 
calcium, and after nifedipine inhibition are shown 
in Fig. 3. Compared to responses in perfusate with 
calcium (1.25 raM), responses in calcium-free 
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Fig. 2. Cumulative results of coronary vascular 
responsiveness to endothelin-1 in the presence of 
an intact endothelium, after endothelium 
damage, and after indomethacin treatment. The 
number of animals is indicated parenthetically. 
Asterisks indicate statistically significant 
(P < 0.05) differences compared to the intact 
preparation. Values are means + standard error 
of mean 
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Fig. 3. a. Representative tracings of  coronary constriction to 
endothelin-1 (10 -9 moles in the presence of 1.25 mM calcium 
in the perfusate, b Effect of endothelin-1 injection after 
coronary vessel perfusion for 20 min with calcium-free 
medium with 1 mM EGTA,  and after reintroduction of cal- 
cium (1.25 mM) into the perfusate, e Cumulative results of 
coronary vascular constriction to endothelin-1 (10 -9 moles in 
the presence of 1.25 mM calcium, reduction of perfusion 
pressure in the absence of extraceilular calcium, endothelin- 
1-induced constriction after reintroduction of calcium into the 
perfusate, and nifedipine inhibition of the constriction. Aster- 
isks indicate statistically significant ( P <  0.05) reduction in 
perfusion pressure in calcium-free medium and significant 
(P<0.005)  inhibition by nifedipine. Values are means + 
standard error of mean for 4-5 animals 
sponse to endothelin-1 in the presence of cal- 
cium). After reintroduction of calcium into the 
perfusate, endothelin-l-induced increases in per- 
fusion pressure were enhanced (70 + 2 mmHg), 
but not significantly, as compared to responses 
observed in experiments where the calcium 
level was not manipulated (42 + 11 mmHg). The 
constriction in response to endothelin-1 observed 
after the reintroduction of calcium was inhibited 
5 9 % + 7 %  by injection of nifedipine (10 -7 
moles). 
Endothelin-1 caused a dose-dependent contrac- 
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Fig. 4. Contraction of the abdominal aorta induced by 
endothelin-1 in rings with intact or rubbed endothelium. 
EDs0 values were significantly reduced in the rubbed prepara- 
tion. The number of animals is indicated parenthetically. 
Asterisks indicate statistically significant (P<0 .05)  differ- 
ences between the intact and rubbed preparations 
onset, in that maximal responses occurred after 4 -  
5 min. After washing the rings for 30 min with 
PSS, 50% of the contraction was still present. 
Figure 4 illustrates that the endothelin-l-induced 
contraction in the intact abdominal aorta was 
about 30% of the maximal contraction to KCI. 
Relaxation responses to acetylcholine (10 -6 M) 
were significantly less in rubbed rings (3% + 4% 
of the response to prostaglandin F2,,) as compared 
to intact rings (77% +_ 7%), indicating that the en- 
dothelium had been sufficiently removed by rub- 
bing. Responses to endothelin-1 were potentiated 
following removal of the endothelium. EDs0 
values to endothelin-1 were increased significantly 
following endothelium removal ( - l o g  EDs0 = 
8.60___ 0.08; antilog = 2.5 × 10 -9 M) compared 
to EDso values for intact rings ( - l o g  EDso = 
8.23 _+ 0.08; antilog, 5.9 × 10 -9 M). Maximal 
responses to endothelin-1 also were significantly 
increased following endothelium removal. Maxi- 
mal KCl-induced contractions were not signifi- 
cantly different for the intact (702 + 125 mg force/ 
mg tissue) as compared to the rubbed rings 
(645 +_ 126 mg force/mg tissue). 
Endothelin-1 caused contraction of aortic rings 
incubated in a calcium-free medium (Fig. 5). The 
magnitude of contraction was approximately 19% 
of the maximal response to endothelin-1 in the 
presence of calcium. Reintroduction of calcium 
produced a marked and rapid contraction which 
was maximal within 5 min and tended to gradually 
wane during the remainder of the 20 min response 
period. 
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Fig. 5. Cumulative results from experiments in the abdomi- 
nal aorta showing statistically significant (P<0.05) reduc- 
tions in tension in calcium-free medium with 1 mM EGTA, 
whereas after reintroduction of 1.6 mM calcium, con- 
traction returned to maximal levels. Values are mean + 
standard error of mean for 8 animals 
Discussion 
The present study demonstrates that endothelin-1 
is a more potent constrictor than prostaglandin 
F2~ in the coronary vasculature. Endothelin-1- 
induced contraction in the abdominal aorta was 
less than that induced by KCI. The magnitude 
of endothelin-l-induced constriction in the coro- 
nary vasculature was not reduced after removal of 
the endothelium or after indomethacin pretreat- 
ment, indicating that the constrictor responses to 
endothelin-1 are not influenced by the release of 
an endothelium-derived contracting factor or con- 
strictor prostaglandin. Further, these findings 
would suggest that it is unlikely that synthetic ex- 
ogenous endothelin-1 stimulates the release of en- 
dogenous endothelin (EDCF) from the endothe- 
lium in coronary vessels, because if a constricting 
factor was released, the response would have been 
enhanced in the presence of an intact endothe- 
lium. Likewise, exogenous endothelin-1 is not 
likely to stimulate the release of the constrictor, 
thromboxane, a phenomenon which occurs in 
guinea pig lung [16]. The magnitude of endothelin- 
1-induced contraction in the abdominal aorta 
was not reduced, but enhanced after endothelium 
removal. These findings are in agreement with 
Auguet  et al. [11] and Saito et al. [12], who re- 
ported small shifts to the left of the endothelin-1 
dose-response curve after endothelium removal in 
arterial ring preparations. These findings suggest 
that in the abdominal aorta, endothelin-1 does not 
stimulate release of a contracting factor from the 
endothelium, but may stimulate the release of a 
dilator factor, possibly endothelium-derived relax- 
ing factor (EDRF).  In the rat mesentery [17], this 
dilator factor may be prostacyclin, but it is not a 
prostaglandin in the abdominal aorta of the guinea 
pig [15]. 
Endothelin-1 induced dilation in the coronary 
vasculature was endothelium-dependent [15]. 
This dependence was first reported by Warner,  
de Nucci, and Vane [18] who used rat endothelin 
in isolated perfused rat mesentery where oxy- 
hemoglobin blocked endothelin-3-induced dila- 
tion. These findings suggest that endothelin-3- 
induced dilation occurs through stimulated release 
of endothelium-derived relaxing factor. In the 
present study, low doses of endothelin-1 did not 
induce relaxation in the abdominal aorta that had 
no resting tone. In another set of experiments, we 
observed relaxation after initially contracting the 
rings by adding prostaglandin F2~ to the bath [15]. 
Observations of constrictor as well as dilator re- 
sponses suggest that endothelin-1 may play a mod- 
ulating role in the local control of vascular tone. 
In calcium-free buffer with 1 mM EGTA,  
coronary perfusion pressure increased to 15%, 
and abdominal aortic ring tension increased to 
19%, of the maximal response to endothelin-1 in 
the presence of calcium. Our findings are in agree- 
ment with Sugiura et al. [8] who found that 20%-  
30% of the maximum contraction in rabbit aortic 
strips remained after calcium-free incubation with 
1 mM EGTA for 20-60 rain. Similarly, Auguet et 
al. [11] found that a slow and sustained contrac- 
tion (29% of the phenylephrine response in con- 
trol medium) was induced after calcium-free treat- 
ment for 20 min. In mesenteric resistance vessels, 
Wallnofer et al. [10] reported that endothelin-1- 
induced contraction in calcium-free medium 
reached 11% of the magnitude of norepinephrine 
contraction in normal PSS. In contrast to these 
studies, Van Renterghem et al. [9] in ra t  aortic 
strips with EGTA,  and Saito et al. [12] in cat cere- 
bral rings without EGTA,  reported no contractile 
response of vessels to endothelin-1 in calcium-free 
medium. For unknown reasons, we found an 
exaggerated constrictor response above control 
values after reintroduction of calcium. Also in the 
present study, endothelin-l-induced constriction 
in the coronary vasculature was inhibited 59% by 
nifedipine (10 .7 moles). Similarly, Watanabe et 
al. [6] found that doses of nifedipine up to 10 -s M 
inhibited 40% of the contraction induced by 
endothelin-1 (10 -7 M) in rabbit aortic rings. In 
contrast to these studies, Auguet et al. [11] found 
that nifedipine, diltiazem, and D-600 had almost 
no effect in inhibiting endothelin-l-induced con- 
traction in rat aortic rings. Recently, studies using 
rabbit aortic smooth muscle cells have reported 
that the initial peak in intracellular calcium levels 
is related to the release of calcium from intracellu- 
lar stores, whereas the plateau or sustained phase 
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is re la ted  to the ent rance  of  extracellular  calcium 
[5]. Since only about  half  of  the endothel in-  
1-induced coronary  constriction is inhibited by 
nifedipine, our  findings suggest that the receptor- 
opera ted  calcium channels,  leak channels,  non- 
specific cation channels,  or sustained intracel- 
lular calcium release must  be instrumental  in 
mediat ing the long-lasting effects of  endothelin-1.  
In conclusion,  our  results indicate that 
endo the l in - l - induced  constr ict ion in the coronary  
vasculature of  the guinea pig is not  media ted  
t h r o u g h  an endogenous  constricting factor  re- 
leased f rom the endothe l ium,  or  by a constr ictor  
prostaglandin.  Fur ther ,  endothe l in - l - induced  
dilation in the coronary  vasculature and at tenua-  
tion of  the endothe l in - l - induced  contract ion in the 
abdominal  aor ta  in the guinea pig are media ted  
through release of a factor  f rom the endothel ium.  
It is not  known why coronary  constrict ion was not  
enhanced  after  endo the l ium damage,  as was the 
case in the aorta  af ter  endothe l ium removal .  
Endo the l in - l - induced  coronary  constriction and 
abdominal  aort ic contract ion require  extracellular  
calcium; enter ing,  in part ,  through nifedipine- 
sensitive channels.  
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